https://orcid.org/0000-0002-8715-5210
Selected Grants
Mid-Atlantic praGmatic NETwork for Inclusive Clinical trials in emergency care (MAGNETIC)
ResearchCo-Principal Investigator · Awarded by National Institute of Neurological Disorders and Stroke · 2023 - 2028CN105 improves surrogate and functional outcomes after intracerebral hemorrhage (Subaward to AegisCN)
ResearchPrincipal Investigator · Awarded by AegisCN LLC · 2024 - 2026Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST-3)
Clinical TrialPrincipal Investigator · Awarded by University of Michigan · 2019 - 2025BREEZE: New Ventricular Direct Cooling Stylet to Mitigate Secondary Brain Injury
ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2025Brain Computed Tomography Repository
Clinical TrialPrincipal Investigator · Awarded by AegisCN LLC · 2023 - 2024USE OF THE NON-INVASIVE, TIME-VARYING BRAINSTEM STIMULATOR IN PATIENTS WITH IMPAIRED CONSCIOUSNESS: A SAFETY AND FEASIBILITY STUDY
Clinical TrialPrincipal Investigator · Awarded by Scion NeuroStim LLC · 2022 - 2024Recovery and Outcome from StrokE (ROSE) (ICH Recovery Grant)
ResearchPrincipal Investigator · Awarded by University of Cincinnati · 2017 - 2023Intrepid- BMD-1111
Clinical TrialPrincipal Investigator · Awarded by Bard Medical Division · 2017 - 2023NICO BrainPath Intracerebral Hemorrhage Evacuation Sample Analysis
ResearchPrincipal Investigator · Awarded by NICO Corporation · 2017 - 2022CN-105 Study
Clinical TrialPrincipal Investigator · Awarded by AegisCN LLC · 2016 - 2021SETPOINT 2: A pragmatic trial to test the effectiveness of early vs. delayed percutaneous tracheostomy in patients with severe stroke and respiratory failure.
Clinical TrialPrincipal Investigator · Awarded by Maine Medical Center Research Institute · 2017 - 2021Genetic and Environmental Risk Factors for Hemorrhagic Stroke
ResearchPrincipal Investigator · Awarded by University of Cincinnati · 2017 - 2020Novartis Phase II BAF312 in Stroke ICH
Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2018 - 2020CN105 to improve long-term recovery in models of intracerebral hemorrhage
ResearchPrincipal Investigator · Awarded by AegisCN LLC · 2018 - 2020Futility study of Deferoxamine Mesylate in Intracerebral Hemorrhage (i-Def)
Clinical TrialPrincipal Investigator · Awarded by Beth Israel Deaconess Medical Center · 2012 - 2019Dova Avatrombopag for Thrombocytopenia
Clinical TrialPrincipal Investigator · Awarded by DOVA Pharmaceuticals · 2018 - 2019Xenon As A Therapeutic in Experimental Intracerebral Hemorrhage
ResearchCo Investigator · Awarded by National Institutes of Health · 2015 - 2018Cephalogics DOT 3.0 in Cerebral Vasospasm
ResearchPrincipal Investigator · Awarded by Cephalogics, LLC · 2016 - 2017External Relationships
- Duke-NUS Medical school
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.